"It's not like we go in our trench coat and a top hat, saying, 'Uh I need the insulin.' The clerks usually don’t know it’s a big secret. They’ll just go, 'Do we sell over-the-counter insulin?' "
Enlibrium's technology, licensed out of UCLA, will use diabetes drug metformin to shut down energy production in cancer cells - providing a potentially new frontline treatment for the disease.
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
The companion app helps users view results of these tests over time so they can do a better job of managing their condition.
Also, Alphabet has filed for a patent for a laser ablation device to remove surgical tissue through electromagnetic radiation.
More than 29 million Americans have diabetes and 86 million have prediabetes. Purdue University researchers are focusing on new innovations in treatment.
A research team at the University of Virginia School of Medicine is looking to automate the monitoring of blood glucose levels and insulin for type 1 diabetes patients.
A three-month experiment in Canada with bimonthly text messages, a Web portal and home-based medical devices produced an average weight decrease of 3.5 pounds and a mean reduction in hemoglobin A1c levels from 7.41 to 6.77 percent in Type 2 diabetics.
Omada Health CEO Sean Duffy views the results as further evidence that even technology challenged seniors can successfully use digital health tools to improve their health.
The point-of-care diagnostics market is continuing to grow - blood testing and monitoring infectious diseases will be much more advanced.
So many health apps, so few users, unless they're sick. But, hey — surprise — HealthMine has the perfect wellness program for those who do use apps.
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
Glooko, a digital health buiness, has added a series of devices to a recently launched platform designed to aggregate not only data from blood-gluose meters and insulin pumps.
Joslin Diabetes Center has named a replacement one week after John Brooks III said he was forced to resign as CEO after five years in the role, according to media reports.
Philips Healthcare has unveiled an app for people with Type 1 diabetes, the first of a series of apps for people with chronic conditions.
More big news for Dexcom. Its G5 continuous glucose monitor will soon be available for use in several European countries.
GlaxoSmithKline's new COPD drug unfortunately failed to extend life in those involved with a major clinical trial, and 50 percent of Americans have diabetes or pre-diabetes, putting them at risk for developing the chronic condition.